{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:43Z","timestamp":1787010163613,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,28]]},"abstract":"<jats:p>\n                    To assess the clinical value of microcystic, elongated, and fragmented (MELF) pattern in Chinese patients with endometrial endometrioid carcinoma. A total of 189 patients with endometrial endometrioid carcinoma were retrospectively analyzed in Peking University Third Hospital from January 2017 to December 2019. We analyzed the association of MELF pattern with the histopathologic data and prognosis of the patients, while immunohistochemistry was performed. The frequency of MELF pattern was 17.99% (34\/189). MELF pattern was associated significantly with tumor size, myometrial invasion, histological grade, International Federation of Gynecology and Obstetrics stages, lymphovascular space invasion, and lymph node metastasis. According to multivariate logistic regression analysis, lymphovascular space invasion [95% confidence interval 1.021\u201348.485,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = .048] was a significant predictor of lymph node involvement. However, MELF pattern was not a significant predictor (95% confidence interval 0.054\u20132.279,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = .400). Loss of expression for mismatch repair proteins was observed in 10 MELF + cases (29.41%) and 54 MELF\u2212 cases (34.84%), respectively. All patients were followed up for 36.8 \u00b1 8.9 months (18\u201354 months). Only 1 patient with MELF pattern was diagnosed with vaginal recurrence 28 months after the surgery. MELF pattern was associated with adverse histologic findings in endometrial endometrioid carcinomas. However, MELF pattern was statistically not a valuable predictor of lymph node metastasis and it needs more studies to show whether MELF pattern has an impact on the prognosis of patients with endometrial endometrioid carcinoma. MELF pattern may be important for identifying those patients who need comprehensive staging surgery.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000031369","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T23:03:45Z","timestamp":1667171025000},"page":"e31369","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Microcystic, elongated and fragmented (MELF) pattern in endometrial carcinoma: clinicopathologic analysis and prognostic implications"],"prefix":"10.1097","volume":"101","author":[{"given":"Jinghua","family":"Song","sequence":"first","affiliation":[{"name":"Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction, Peking University, Ministry of Education, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7057-7134","authenticated-orcid":false,"given":"Huajun","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction, Peking University, Ministry of Education, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Guo","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction, Peking University, Ministry of Education, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Cai","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction, Peking University, Ministry of Education, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.pas.0000152129.81363.d2","article-title":"Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems.","volume":"29","author":"Alkushi","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PGP.0b013e318285657b","article-title":"Lymphovascular space invasion in microcystic elongated and fragmented (MELF)-pattern well-differentiated endometrioid adenocarcinoma is associated with a higher rate of lymph node metastasis.","volume":"33","author":"Hertel","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-2559.2011.03802.x","article-title":"MELF invasion in endometrial cancer as a risk factor for lymph node metastasis.","volume":"58","author":"Pavlakis","year":"2011","journal-title":"Histopathol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/01443615.2014.960827","article-title":"The association of the microcystic, elongated, and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis.","volume":"35","author":"Dogan Altunpulluk","year":"2015","journal-title":"J Obstet Gynaecol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1097\/PAS.0b013e318299f2ab","article-title":"The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.","volume":"37","author":"Euscher","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/his.13977","article-title":"Revising the WHO classification: female genital tract tumours.","volume":"76","author":"Cree","year":"2020","journal-title":"Histopathology"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1933719110368433","article-title":"Minor serous and clear cell components adversely affect prognosis in \u201cmixed-type\u201d endometrial carcinomas: a clinicopathologic study of 36 stage-I cases.","volume":"17","author":"Quddus","year":"2010","journal-title":"Reprod Sci"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/gyno.1994.1158","article-title":"Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma.","volume":"54","author":"Lee","year":"1994","journal-title":"Gynecol Oncol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pgp.0000092161.33490.a9","article-title":"Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.","volume":"22","author":"Murray","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12253-017-0320-5","article-title":"Association between morphological patterns of myometrial invasion and cancer stem cell markers in endometrial endometrioid carcinoma.","volume":"25","author":"Park","year":"2019","journal-title":"Pathol Oncol Res"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PAS.0000000000000754","article-title":"The microcystic, elongated, and fragmented (MELF) pattern of invasion: a single institution report of 464 consecutive FIGO grade 1 endometrial endometrioid adenocarcinomas.","volume":"41","author":"Joehlin-Price","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/PAS.0000000000000856","article-title":"Clinicopathologic association and prognostic value of microcystic, elongated, and fragmented (MELF) pattern in endometrial endometrioid carcinoma.","volume":"41","author":"Kihara","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R13-20250504","first-page":"13","article-title":"Clinicopathological significance and prognostic value of myoinvasive patterns in endometrial endometrioid carcinoma.","volume":"59","author":"Am\u0103linei","year":"2018","journal-title":"Rom J Morphol Embryol"},{"key":"R14-20250504","first-page":"77","article-title":"MELF pattern in myometrial infiltration in endometrioid adenocarcinoma of the endometrium. A retrospective study of 70 cases.","volume":"51","author":"Tresserra","year":"2018","journal-title":"Rev Esp Patol"},{"key":"R15-20250504","first-page":"54","article-title":"The clinical pathological features and prognostic value of microcystic, elongated and fragmented pattern in endometrioid adenocarcinoma.","volume":"35","author":"Han","year":"2019","journal-title":"J Practical Obstet Gynaecol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/IGC.0000000000001070","article-title":"Identifiable risk factors for lymph node metastases in grade 1 endometrial carcinoma.","volume":"27","author":"Pavlakis","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/PGP.0000000000000370","article-title":"MELF pattern for predicting lymph node involvement and survival in Grade I-II endometrioid-type endometrial cancer.","volume":"37","author":"Sanci","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00404-020-05600-8","article-title":"Systematic lymphadenectomy in early stage endometrial cancer.","volume":"302","author":"Ignatov","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ygyno.2019.03.254","article-title":"Sentinel node mapping vs. lymphadenectomy in endometrial cancer: a systematic review and meta-analysis.","volume":"153","author":"Bogani","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.bulcan.2017.10.006","article-title":"European guidelines (ESMO-ESGO-ESTRO consensus conference) for the management of endometrial cancer.","volume":"104","author":"Ballester","year":"2017","journal-title":"Bull Cancer"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejogrb.2018.09.036","article-title":"MELF pattern of myometrial invasion and role in possible endometrial cancer diagnostic pathway: a systematic review of the literature.","volume":"230","author":"Prodromidou","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2020.07.102","article-title":"POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women.","volume":"159","author":"He","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2018.08.020","article-title":"Does MMR status in endometrial cancer influence response to adjuvant therapy?","volume":"151","author":"Kim","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.3802\/jgo.2018.29.e39","article-title":"Endometrial cancer risk and survival by tumor MMR status.","volume":"29","author":"Nagle","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1002\/cncr.32203","article-title":"Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?","volume":"125","author":"Kahn","year":"2019","journal-title":"Cancer"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejso.2020.06.041","article-title":"Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasion.","volume":"47","author":"Santoro","year":"2021","journal-title":"Eur J Surg Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:33:09Z","timestamp":1746318789000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":26,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031369","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,28]]}}}